US FDA uncertain about supply timeline of Novo Nordisk's weight loss drug
U.S. Food and Drug Administration on Tuesday changed its estimate for the availability of lower doses of Novo Nordisk's weight-loss drug Wegovy to "to be decided" from its earlier expectation of Se...
Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here's what we know
Scientists hope that a new class of treatments for alcohol use disorder, smoking and other addictive behaviors is on the horizon.
3 Top Healthcare Stocks to Buy for September
UnitedHealth Group is a foundational piece of the healthcare system in America. Demand for Pfizer's Covid vaccine may have waned, but profits are going to good use.
1 Stock Split Stock to Buy Hand Over Fist Right Now
Novo Nordisk is seeing unprecedented growth as demand surges for its diabetes and weight-loss treatments. Following its Q2 earnings release, the company announced a 2-for-1 stock split, which is se...
Why Novo Nordisk Stock Topped the Market on Thursday
The JPMorgan Chase analyst team tracking the European pharmaceutical company boosted its price target. "Boosted" might be an understatement, as the figure was raised by 25%.
Wegovy drugmaker Novo Nordisk to make $70bn a year from weight-loss alone, as analysts await full SELECT trial data
As researchers work to test whether Novo Nordisk (NYSE:NVO)'s fat-busting drug Wegovy can also be used as a treatment for dementia and alcohol addiction, some analysts are pointing to a potential "...
Novo Nordisk Is Already Working on Ozempic 2.0. Here's How to Profit
Novo Nordisk is keen to replicate Ozempic's success. It just made two acquisitions that could lead to another big victory.
Novo Nordisk (NVO) Launches Wegovy in UK Amid Supply Issues
Novo Nordisk (NVO) announces the controlled and limited launch of Wegovy in the U.K. amid rising demand for weight loss treatment and supply constraints.
Novo Nordisk Becomes Europe's Most Valuable Company as Wegovy Launches in UK
American depositary receipts of Novo Nordisk (NVO) climbed 1.5% in early trading on Tuesday after launching its popular weight-loss drug, Wegovy, in the U.K.
Wegovy supply from Novo Nordisk has arrived in UK, Simple Online Pharmacy says
UK-based Simple Online Pharmacy has received stock of Novo Nordisk's weight-loss drug Wegovy, a company spokesperson said on Tuesday, one day after Novo launched the drug in Britain.
Novo Nordisk rolls out its weight loss drug Wegovy in the U.K.
Novo Nordisk A/S (NYSE: NVO) is in focus on Monday after it launched its weight loss drug in another European market – the United Kingdom. Novo Nordisk is facing supply constraints But the pharmace...
Pent-up private Wegovy demand prompts UK availability concerns
People in Britain who can afford to pay out of their own pocket may get easier access to Novo Nordisk's weight-loss drug Wegovy than those seeking treatment in the country's state-run health servic...
‘Miracle' weight-loss drug Wegovy will not be issued through major insurers
Several prominent UK-based insurers including Aviva, Axa, and WPA will not cover the costs of the newly launched weight-loss drug, Wegovy, under their private medical insurance policies. Since ins...
Novo Nordisk's Wegovy weight loss drug launches in the UK
Novo Nordisk launched its Wegovy weight loss injection in the U.K. Monday, furthering the drug's rollout in Europe despite ongoing supply constraints.
Factbox: Launches of Novo Nordisk's weight-loss drug Wegovy
Novo Nordisk is pushing ahead with the launches of weight-loss drug Wegovy in Europe even as it struggles to keep up with demand. The Danish drugmaker is working to convince European governments an...
Related Companies